BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G Report for Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Amylyx Pharmaceuticals, Inc. Common Stock
Symbol: AMLX
Shares outstanding: 89,409,109 shares
Disclosed Ownership: 4,917,501 shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Filing time: 17 Jul 2025, 19:44:53 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.5%	4,917,501	4,827,647	0	Spencer Fleming	Managing Director